Knockdown of VEGFR3 expression with siRNA in colorectal or breast cancer cell lines has been shown to reduce tumor cell proliferation in vitro and to significantly inhibit tumor growth in vivo [35, 36], indicating that VEGFR3 inhibition is sufficient to inhibit tumor growth. Here, FLT4 is linked to neoplasm.